Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial
Clinical trial NCT05173896 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05173896
- Sponsor
- Christina Kruuse
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2024-09-23
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.